Professor Pan Jianping, the company's chief scientist (a doctoral supervisor at the Zhejiang University School of Medicine), and Professor Zhang Lifang from the R&D department (a doctoral supervisor at Wenzhou Medical University) form the core R&D team. Leveraging cutting-edge biotechnology platforms and integrating extensive market research with clinical feedback, they are dedicated to providing customers with high-quality, efficient one-stop cell pathology solutions. The company has filed six invention patents, with three already authorized. Guided by the corporate culture of "Integrity, Excellence, Innovation, and Responsibility," it continues to deliver premium products and comprehensive services to clients.